how are glp-1 drugs manufactured The boom: Challenges, trends, and CapEx strategies for manufacturers Designing GLP-1 delivery: structural perspectives

FEBS Lett 581:29472953 Eydallin G, Montero M, Almagro G, Sesma MT, Viale AM, Muoz FJ, Rahimpour M, Baroja-Fernndez E, Pozueta-Romero J (2010) Genome-wide screening of genes whose enhanced expression affects glycogen accumulation in Escherichia coli

I would be very interested on your take on two things1) the very high discontinuation rate of these drugs (and the corresponding need for a focus on behavior change as an adjuvant/parallel to course of treatment) and, 2) the impact of significant lean muscle and bone loss during treatment w/GLP-1s

shading light

Discover Nano (2023) 18(1):111

Additionally, a very small percentage of B12 from a supplemental dose is absorbed by passive diffusion